“I am very pleased to welcome Marina to our Board of Directors,” said Celyad Oncology CEO Filippo Petti. “As a highly regarded leader in the biopharmaceutical industry, we look forward to benefiting from Marina’s wealth of experience as we continue to advance key elements of our pipeline with the goal of developing innovative cell therapies against cancer.”
Dr. Udier is the CEO of private oncology company Nouscom, where she has served for four and a half years. She has more than 20 years of healthcare experience, also including roles with Versant Ventures, Novartis Pharma, and McKinsey & Company.
“Celyad Oncology is at a pivotal moment in its company history with multiple candidates in the clinic and a promising array of significant milestones expected in 2021,” said Dr. Udier. “I am honored to be part of the Celyad Oncology Board and look forward to working with the talented team to execute on the company’s strategic vision of establishing itself as an industry leader in the CAR T space.”